eXoZymes Statistics
Share Statistics
eXoZymes has 8.39M
shares outstanding. The number of shares has increased by null%
in one year.
| 8.39M |
| n/a |
| n/a |
| n/a |
| n/a |
| 1 |
| 0.02% |
Short Selling Information
The latest short interest is 17.01K, so 0.2% of the outstanding
shares have been sold short.
| 17.01K |
| 0.2% |
| 0.26% |
| 2.06 |
Valuation Ratios
The PE ratio is -22.88 and the forward
PE ratio is null.
eXoZymes's PEG ratio is
-0.12.
| -22.88 |
| n/a |
| 0 |
| n/a |
| 12.87 |
| -15.06 |
| -0.12 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for eXoZymes.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 8.12,
with a Debt / Equity ratio of 0.13.
| 8.12 |
| 8.12 |
| 0.13 |
| -0.24 |
| -0.16 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-189.08K |
| 31 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 1.31, so eXoZymes's
price volatility has been higher than the market average.
| 1.31 |
| n/a |
| 10.22 |
| n/a |
| 34.41 |
| 6,177 |
Income Statement
| n/a |
| -267.38K |
| -5.93M |
| -5.86M |
| -5.66M |
| -5.93M |
| -0.72 |
Full Income Statement Balance Sheet
The company has 9.72M in cash and 1.39M in
debt, giving a net cash position of 8.33M.
| 9.72M |
| 1.39M |
| 8.33M |
| -11.95M |
| 9.68M |
| 6.31M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -8.51M
and capital expenditures -396.45K, giving a free cash flow of -8.9M.
| -8.51M |
| -396.45K |
| -8.9M |
| -1.1 |
Full Cash Flow Statement Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |